GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aurobindo Pharma Ltd (NSE:AUROPHARMA) » Definitions » 5-Year Yield-on-Cost %

Aurobindo Pharma (NSE:AUROPHARMA) 5-Year Yield-on-Cost % : 0.84 (As of May. 14, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Aurobindo Pharma 5-Year Yield-on-Cost %?

Aurobindo Pharma's yield on cost for the quarter that ended in Dec. 2023 was 0.84.


The historical rank and industry rank for Aurobindo Pharma's 5-Year Yield-on-Cost % or its related term are showing as below:

NSE:AUROPHARMA' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.51   Med: 0.9   Max: 3.83
Current: 0.84


During the past 13 years, Aurobindo Pharma's highest Yield on Cost was 3.83. The lowest was 0.51. And the median was 0.90.


NSE:AUROPHARMA's 5-Year Yield-on-Cost % is ranked worse than
77.49% of 502 companies
in the Drug Manufacturers industry
Industry Median: 2.095 vs NSE:AUROPHARMA: 0.84

Competitive Comparison of Aurobindo Pharma's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Aurobindo Pharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aurobindo Pharma's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aurobindo Pharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Aurobindo Pharma's 5-Year Yield-on-Cost % falls into.



Aurobindo Pharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Aurobindo Pharma is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Aurobindo Pharma  (NSE:AUROPHARMA) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Aurobindo Pharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Aurobindo Pharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aurobindo Pharma (NSE:AUROPHARMA) Business Description

Traded in Other Exchanges
Address
Plot No. 1, Survey No. 83/1, Galaxy, Floors: 22-24, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District, Hyderabad, TG, IND, 500 032
Aurobindo Pharma Ltd is a specialty and generic drug manufacturing company. The company's product portfolio spans a variety of therapeutic areas. The vast majority of the company's sales are generated in the United States, followed by Europe. Most of Aurobindo's sales are derived from its formulations business, with the rest stemming from its active pharmaceutical ingredient operations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Aurobindo Pharma (NSE:AUROPHARMA) Headlines

No Headlines